DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Dhainaut JF, Laterre PF, Janes JM. et al.
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial
Intensive Care Med 2003; 29: 894-903
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.